A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Eisai Inc.
BeiGene
Columbia University
City of Hope Medical Center
Columbia University
Pfizer
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Northwestern University
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
University of Nebraska
University of Nebraska
Columbia University
OncoSec Medical Incorporated
Stanford University
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Soligenix
miRagen Therapeutics, Inc.
Alexion Pharmaceuticals, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
Northwestern University
Novartis
Novartis
Roswell Park Cancer Institute
Eisai Inc.
Roswell Park Cancer Institute
Galderma R&D
Fred Hutchinson Cancer Center
Takeda
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Eli Lilly and Company
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Mayo Clinic
Helsinn Therapeutics (U.S.), Inc
Fred Hutchinson Cancer Center